Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering. Product Details | Order

Business Description
Bristol-Myers Squibb Company produces and distributes medicines and related healthcare products. Some of the Company's products are Pravachol (pravastatin sodium), a lipid-lowering agent indicated for prevention of coronary heart disease and secondary prevention of cardiovascular events; Plavix (clopidogrel), a platelet inhibitor, and Avapro (irbesartan), an anti-hypertensive agent, both codeveloped and jointly marketed with Sanofi-Synthelabo; anti-cancer agents, including Taxol (paclitaxel) and Paraplatin (carboplatin); HIV/AIDS therapies Sustiva (efavirenz), Zerit (stavudine) and Videx (didanosine); Excedrin brand non-prescription pain relievers; medical imaging products including Cardiolite (for the preparation of Technetium Tc99m Sestamibi for Injection) and Definity Vial For (Perflutren Lipid Microsphere) Injectable Suspension; Enfamil infant formulas produced by the Mead Johnson Nutritionals division; and ostomy and modern wound care products produced by the ConvaTec division.

Financial Information
Bristol-Myers Squibb Company is a global producer and distributor of a variety of pharmacueticals and related healthcare products. For the six months ended 6/30/02, net sales fell 13% to $8.14 billion. Net income from continuing operations fell 56% to $1.03 billion. Results reflect decreased volume and selling prices of pharmaceutical products and the inclusion of a $112 million acquired research and development charge.